ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.175,21
1,01%
S&P 500
5.156,62
0,56%
Dow Jones
38.726,48
0,13%
Euro vs US Dollar
1,07748
0,16%
Bitcoin
63.596,02
-0,63%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Lucid Diagnostics Inc (LUCD)

  7. Lucid Diagnostics Inc (LUCD) News

LUCD Lucid Diagnostics Inc

1,04
0,1103 (11,86%)
Zuletzt aktualisiert: 18:15:17
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Lucid Diagnostics Inc LUCD NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,1103 11,86% 1,04 18:15:17
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,96 0,94 1,07 0,9297
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
02.5.202414:35PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
02.5.202413:49PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
29.4.202414:47PRNUSLucid Diagnostics Partners with the Esophageal Cancer Action..
08.4.202414:30PRNUSLucid Diagnostics to Participate in Fireside Chat at the..
27.3.202400:32PRNUSPAVmed Provides Business Update and Fourth Quarter and Full..
25.3.202422:30PRNUSLucid Diagnostics Provides Business Update and Preliminary..
21.3.202414:30PRNUSLucid Diagnostics Announces Positive Data from the First..
20.3.202413:30PRNUSLucid Diagnostics Announces Multiple Presentations at the..
12.3.202413:30PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
23.2.202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16.2.202423:00PRNUSLucid Diagnostics Provides Update Regarding World Trade..
15.2.202413:45PRNUSLucid Diagnostics Chairman & CEO, Dr. Lishan Aklog,..
08.2.202413:45PRNUSLucid Diagnostics Executes Contract to Provide EsoGuard®..
06.2.202423:24EDGAR2Form S-8 - Securities to be offered to employees in employee..
06.2.202423:20EDGAR2Form S-8 - Securities to be offered to employees in employee..
30.1.202423:00EDGAR2Form 8-K - Current report
12.12.202314:30PRNUSLucid Diagnostics Announces Peer-Reviewed Publication of..
11.12.202315:00PRNUSPAVmed Provides Additional Details for Upcoming Stock..
04.12.202322:20PRNUSPAVmed Announces Dividend of Lucid Diagnostics Common Stock..
28.11.202322:30EDGAR2Form 8-K - Current report
24.11.202322:05EDGAR2Form 8-K - Current report
16.11.202315:00PRNUSLucid Diagnostics Strengthens and Expands Market Access and..
14.11.202323:43PRNUSPAVmed Provides Business Update and Third Quarter Financial..
14.11.202303:40EDGAR2Form 8-K - Current report
13.11.202323:40PRNUSLucid Diagnostics Provides Business Update and Third Quarter..
13.11.202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:35EDGAR2Form 8-K - Current report
09.11.202315:00PRNUSLucid Diagnostics Launches Next-Generation EsoGuard®..
02.11.202314:18PRNUSLucid Diagnostics to Present at Canaccord Genuity Medtech,..
01.11.202321:21EDGAR2Form D - Notice of Exempt Offering of Securities
01.11.202314:10PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
31.10.202314:00PRNUSLucid Diagnostics Announces PREVENT and PREVENT-FF..
31.10.202313:55PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
18.10.202315:15EDGAR2Form 8-K - Current report
21.9.202314:30PRNUSPAVmed and Lucid Diagnostics to Participate in Panel..
07.9.202315:26PRNUSLucid Diagnostics Releases Positive Data from First..
06.9.202315:00PRNUSLucid Diagnostics Releases Positive Data Demonstrating..
24.8.202315:00PRNUSLucid Diagnostics Executes First Direct Employer Contract to..
16.8.202302:17PRNUSPAVmed Provides Business Update and Second Quarter Financial..
15.8.202300:48PRNUSLucid Diagnostics Provides Business Update and Second..
14.8.202322:45EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01.8.202300:19PRNUSPAVmed to Hold a Business Update Conference Call and Webcast..
01.8.202300:00PRNUSLucid Diagnostics to Hold a Business Update Conference Call..
26.7.202314:30PRNUSLucid Diagnostics to Present at the Canaccord Genuity 43rd..
19.7.202315:04PRNUSPAVmed and Lucid Chairman and Chief Executive Officer, Dr...
28.6.202322:05PRNUSPAVmed Receives 180-Day Extension to Regain Compliance with..
14.6.202322:05PRNUSPAVmed to Participate in Healthcare Virtual Conference..
05.6.202313:00PRNUSLucid Diagnostics Launches First EsoGuard® Mobile Test Unit
02.6.202313:00PRNUSPAVmed Digital Health Subsidiary, Veris Health, Joins Cancer..
16.5.202323:00PRNUSPAVmed Provides Business Update and First Quarter Financial..

Kürzlich von Ihnen besucht

NASDAQ
LUCD
Lucid Diagnostics
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten